Canada markets closed

Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.73-0.16 (-1.47%)
At close: 04:00PM EDT
10.73 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
2,594
682
0
0
0
-
Cost of Revenue
593
167
0
-
-
-
Gross Profit
2,001
515
0
-
-
-
Operating Expenses
Research Development
47,850
49,899
71,441
72,338
98,148
-
Selling General and Administrative
161,340
117,928
100,999
62,742
27,517
-
Total Operating Expenses
209,190
167,827
172,440
135,080
125,665
-
Operating Income or Loss
-207,189
-167,312
-172,440
-135,080
-125,665
-
Interest Expense
49,919
41,968
27,305
6,788
4,581
-
Total Other Income/Expenses Net
-251
-188
-110
-2,056
87
-
Income Before Tax
-246,630
-201,592
-197,723
-143,883
-129,068
-
Income from Continuing Operations
-246,630
-201,592
-197,723
-143,883
-129,068
-
Net Income
-246,630
-201,592
-197,723
-143,883
-129,068
-
Net Income available to common shareholders
-246,630
-201,592
-197,723
-143,883
-129,068
-
Basic EPS
-3.81
-
-5.05
-3.89
-3.88
-22.45
Diluted EPS
-3.81
-
-5.05
-3.89
-3.88
-22.45
Basic Average Shares
47,283
-
39,118
37,003
33,228
11,367
Diluted Average Shares
47,283
-
39,118
37,003
33,228
11,367